On March 4, InMed Pharmaceuticals Confirmed And Approved The Decision To Wind Down BayMedica's Commercial Operations; BayMedica To Complete Wind Down Before Fiscal Year Ending June 30, 2026

On March 4, InMed Pharmaceuticals confirmed the decision to wind down BayMedica's commercial operations, with the completion expected before the fiscal year ending June 30, 2026. This strategic move indicates a shift in focus for InMed Pharmaceuticals as it restructures its business operations.